Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
GEHC 
GE HealthCare Technologies Inc. (GEHC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: GEHC (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
21 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $88
1 Year Target Price $88
| 12 | Strong Buy |
| 4 | Buy |
| 5 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 11.44% | Avg. Invested days 36 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 09/15/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 34.90B USD | Price to earnings Ratio 15.66 | 1Y Target Price 88 |
Price to earnings Ratio 15.66 | 1Y Target Price 88 | ||
Volume (30-day avg) 21 | Beta 1.28 | 52 Weeks Range 57.59 - 94.71 | Updated Date 09/14/2025 |
52 Weeks Range 57.59 - 94.71 | Updated Date 09/14/2025 | ||
Dividends yield (FY) 0.13% | Basic EPS (TTM) 4.88 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 11.22% | Operating Margin (TTM) 14.62% |
Management Effectiveness
Return on Assets (TTM) 5.77% | Return on Equity (TTM) 25.8% |
Valuation
Trailing PE 15.66 | Forward PE 16.61 | Enterprise Value 41878602108 | Price to Sales(TTM) 1.75 |
Enterprise Value 41878602108 | Price to Sales(TTM) 1.75 | ||
Enterprise Value to Revenue 2.1 | Enterprise Value to EBITDA 10.96 | Shares Outstanding 456561984 | Shares Floating 455233441 |
Shares Outstanding 456561984 | Shares Floating 455233441 | ||
Percent Insiders 0.27 | Percent Institutions 87.11 |
Upturn AI SWOT
GE HealthCare Technologies Inc.
Company Overview
History and Background
GE HealthCare Technologies Inc. was officially spun off from General Electric in January 2023. It traces its roots back to the late 19th century with the development of X-ray technology. Over the years, it evolved into a leading provider of medical imaging, diagnostics, and healthcare IT solutions.
Core Business Areas
- Imaging: Offers a comprehensive portfolio of medical imaging solutions, including MRI, CT, X-ray, ultrasound, and nuclear medicine. These products are used for diagnosis, treatment planning, and monitoring of various medical conditions.
- Ultrasound: Provides ultrasound systems for a range of applications, including radiology, cardiology, obstetrics and gynecology, and point-of-care imaging.
- Patient Care Solutions: Develops and manufactures patient monitoring systems, anesthesia delivery systems, and respiratory care products used in hospitals and clinics.
- Pharmaceutical Diagnostics: Focuses on contrast media and molecular imaging agents used to enhance medical images and improve diagnostic accuracy.
Leadership and Structure
Peter Arduini serves as the President and CEO. The company operates with a decentralized structure, organized around its core business segments.
Top Products and Market Share
Key Offerings
- Competitors: Siemens Healthineers, Philips, Canon Medical Systems
- MRI Systems: GE HealthCare is a leading provider of MRI systems used for a wide range of clinical applications. Competitors include Siemens Healthineers and Philips. Market share estimated around 25% globally.
- Number of Systems: Over 50,000 MRI systems globally.
- CT Scanners: Offers a comprehensive portfolio of CT scanners used for diagnostic imaging. Competitors include Siemens Healthineers and Philips. Market share estimated around 23% globally.
- Competitors: Siemens Healthineers, Philips, Canon Medical Systems
- Number of Scanners: Over 40,000 CT scanners globally
- Competitors: Philips, Siemens Healthineers, Canon Medical Systems
- Market Share: GE held approximately 18% of the global ultrasound market share.
- Ultrasound Systems: Provides ultrasound systems across various clinical applications including Radiology, Cardiology, OB/GYN and Point-of-Care.
Market Dynamics
Industry Overview
The healthcare technology industry is experiencing growth due to an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. The industry is highly regulated and competitive.
Positioning
GE HealthCare holds a leading position in the medical imaging and diagnostics market, driven by its established brand, comprehensive product portfolio, and global reach. They are focused on precision health and personalized medicine.
Total Addressable Market (TAM)
The global medical device market is projected to reach approximately $600 billion by 2028. GE HealthCare is well-positioned to capture a significant portion of this TAM through its diverse product offerings and strategic initiatives.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Extensive product portfolio
- Global presence
- Technological innovation
- Large installed base
Weaknesses
- High debt levels post-spin-off
- Dependence on hospital capital spending
- Complex organizational structure
- Integration challenges with acquired businesses
Opportunities
- Growing demand for medical imaging and diagnostics
- Expansion into emerging markets
- Development of AI-powered solutions
- Strategic acquisitions
- Partnerships and collaborations
Threats
- Intense competition
- Price pressure from healthcare providers
- Regulatory changes
- Economic downturns
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- SIEM
- PHG
- TMO
- DHR
Competitive Landscape
GE HealthCare benefits from its brand recognition, comprehensive solutions, and strong installed base, but faces intense competition from Philips, Siemens Healthineers and other players. A key area of focus will be innovation in AI and data analytics to maintain its competitive edge.
Major Acquisitions
Caption Health
- Year: 2023
- Acquisition Price (USD millions):
- Strategic Rationale: Augments GE HealthCare's ultrasound business with AI-powered software, enhancing diagnostic capabilities and workflow efficiency.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is based on GE's historical healthcare business segment. This is not an accurate representation of GE Healthcare performance now.
Future Projections: Analyst projections for GE HealthCare's future growth anticipate revenue growth driven by innovation in key segments and expansion into emerging markets. EPS is expected to increase steadily over the next few years.
Recent Initiatives: Recent initiatives include the introduction of new AI-powered imaging solutions, strategic partnerships with healthcare providers, and expansion of its digital health platform.
Summary
GE HealthCare is a strong player in the medical imaging and diagnostics market, backed by a well-known brand, and wide range of products. The spin-off brings increased focus, but carries higher debt. Future growth hinges on product innovation and market expansion, while navigating a competitive landscape. They have several companies and partners that they face competition from.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
- Company Investor Relations
- Third Party Data
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share estimates are approximate and may vary based on source. Forward-looking statements are subject to risks and uncertainties.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About GE HealthCare Technologies Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 2023-01-04 | President, CEO & Director Mr. Peter J. Arduini | ||
Sector Healthcare | Industry Health Information Services | Full time employees 53000 | Website https://www.gehealthcare.com |
Full time employees 53000 | Website https://www.gehealthcare.com | ||
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.